Predicting Parkinson’s: Using Neural Networks to Evaluate the Genetic Risk Factors Behind the Disease

Authors

  • Andrew Yuan Lynbrook
  • Isha Jagadish Saratoga High School
  • Trisha Gongalore Mountain View High School
  • Joseph Alzagatiti Mentor, University of California Santa Barbara

DOI:

https://doi.org/10.47611/jsrhs.v10i3.1624

Keywords:

parkinson's, machine learning, neural networks, prediction, genomic data, risk factors

Abstract

To date, researchers do not know the exact reasons for the loss of dopaminergic neurons in the substantia nigra pars compacta that leads to Parkinson’s Disease (PD). Thus, it is extremely difficult to predict whether or not a patient is likely to develop the disease later on, as their risk increases with age. However, once patients present with the common symptoms indicative of the illness, a substantial amount of dopaminergic neurons are already lost. Seeing as there are no current avenues of replacing those neurons, predictive diagnosis and preventive measures could be of extraordinary help in devising treatments. Our aim was to use the significant research into possible high-risk genetic factors from genome-wide association studies (GWAS) to formulate a predictive neural network model for Parkinson’s. We analyzed patient genomes for mutations in the top 20 genes associated with PD, as well as 21 genes implicated in axon guidance pathways, to determine whether the patients were at high or low risk for Parkinson’s. Our model produced an accuracy and AUROC of 94%. We found this significant because it showed a strong correlation between the single nucleotide polymorphisms (SNPs) we analyzed and PD. We believe our model can be further improved upon by adding considerations for other investigated risk factors, such as patient age, familial history of disease, or gut microbiota inconsistencies among others.

Downloads

Download data is not yet available.

References or Bibliography

NINDS. (2020) Parkinson's Disease: Hope Through Research. NIH Publication 20,139. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Parkinsons-Disease-Hope-Through-Research#whatis

Shahmoradian, S.H., Lewis, A.J., Genoud, C. et al. (2019) Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22, 1099–1109. https://doi.org/10.1038/s41593-019-0423-2

Chaudhuri, R., Healy, D., Schapira, A. (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. The Lancet Neurology 5 (3), 235-245. https://www.sciencedirect.com/science/article/abs/pii/S1474442206703738

Rascol, O., Payoux, P., Ory, F., Ferreira, J., Brefel-Courbon, C., Montastruc, J. (2003) Limitations of current Parkinson’s disease therapy. Annals of Neurology 53 (S3). https://doi.org/10.1002/ana.10513

Postuma, R., Berg, D. (2016). Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12, 622–634. https://doi.org/10.1038/nrneurol.2016.152

Thomas, B., Beal, M. (2007) Parkinson’s disease. Human Molecular Genetics 16 (R2), 183–194. https://doi.org/10.1093/hmg/ddm159

Maraganore, D., Andrade M., Lesnick, T., Frazer, K., Cox, D., Ballinger, D. et al. (2005) High-Resolution Whole-Genome Association Study of Parkinson Disease. American Journal of Human Genetics 77, 685-693. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1271381/#ui-ncbiinpagenav-heading-3

Livesey FJ, Hunt SP (1997) Netrin and netrin receptor expression in the embryonic mammalian nervous system suggests roles in retinal, striatal, nigral, and cerebellar development. Mol Cell Neurosci 8, 417–429. https://doi.org/10.1006/mcne.1997.0598

Berus, L., Klancnik, S., Brezocnik, M., & Ficko, M. (2018). Classifying Parkinson's Disease Based on Acoustic Measures Using Artificial Neural Networks. Sensors (Basel, Switzerland), 19(1), 16. https://doi.org/10.3390/s19010016

Gil-Martín, M., Montero, J., San-Segundo, R. (2019) Parkinson’s Disease Detection from Drawing Movements Using Convolutional Neural Networks. MDPI electronics 8(8), 907. https://doi.org/10.3390/electronics8080907

Maachi, I., Bilodeau, G., Bouachir, W., (2019) Deep 1D-Convnet for accurate Parkinson disease detection and severity prediction from gait, Cornell arXiv. arXiv:1910.11509

Team, W. (2002). HapMap 3. Wellcome Sanger Institute. ftp.ncbi.nlm.nih.gov/hapmap/phase_3/hapmap3_reformatted/

Lesnick, T., Papapetropoulos, S., Mash, D., French-Mullen, J., Shehadeh, L., de Andrade, M., et al. (2007) A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease. PLoS Genet 3(6), 98. https://doi.org/10.1371/journal.pgen.0030098

Landis, R., Koch, G. (1977) The measurement of observer agreement for categorical data. Biometrics 33(1), 159-174. https://pubmed.ncbi.nlm.nih.gov/843571/

Published

10-10-2021

How to Cite

Yuan, A., Jagadish, I., Gongalore, T., & Alzagatiti, J. (2021). Predicting Parkinson’s: Using Neural Networks to Evaluate the Genetic Risk Factors Behind the Disease. Journal of Student Research, 10(3). https://doi.org/10.47611/jsrhs.v10i3.1624

Issue

Section

HS Research Articles